Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Biological Psychiatry|July 5, 2003
Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodentsJohn F Cryan, Daniel Hoyer, Athina Markou
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 22, 2020
SMAD4 protein is decreased in the dorsolateral prefrontal and anterior cingulate cortices in schizophreniaAndrew S Gibbons, Daniel Hoyer, Brian Dean
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 5, 2003
Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806Caroline Nunn, Philippe Schoeffter, Daniel Langenegger, et al.
Pharmacology & Therapeutics|September 27, 2005
Interfering with the brain: use of RNA interference for understanding the pathophysiology of psychiatric and neurological disordersDeepak R Thakker, Daniel Hoyer, John F Cryan
Expert Review of Clinical Pharmacology|October 17, 2014
Suvorexant for the treatment of insomniaLaura H Jacobson, Gabrielle E Callander, Daniel Hoyer
Angewandte Chemie (International Ed. in English)|May 2, 2018
Synthesis and Biological Evaluation of a Cyclo-β-tetrapeptide as a Somatostatin AnalogueKarl Gademann, Martin Ernst, Daniel Hoyer, et al.
Neuropharmacology|September 24, 2004
The somatostatin receptor (sst1) modulates the release of somatostatin in the nucleus accumbens of the ratAnna Vasilaki, Despina Papasava, Daniel Hoyer, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2002
Molecular, pharmacological and functional diversity of 5-HT receptorsDaniel Hoyer, Jason P Hannon, Graeme R Martin
Pharmacology & Therapeutics|November 9, 2005
The somatostatin sst1 receptor: an autoreceptor for somatostatin in brain and retina?Kyriaki Thermos, Paola Bagnoli, Jacques Epelbaum, et al.
Pageof 15